Immix Biopharma Inc
NASDAQ:IMMX

Watchlist Manager
Immix Biopharma Inc Logo
Immix Biopharma Inc
NASDAQ:IMMX
Watchlist
Price: 2.27 USD 3.65% Market Closed
Market Cap: 63.3m USD

Intrinsic Value

The intrinsic value of one IMMX stock under the Base Case scenario is 3.08 USD. Compared to the current market price of 2.27 USD, Immix Biopharma Inc is Undervalued by 26%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

IMMX Intrinsic Value
3.08 USD
Undervaluation 26%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Immix Biopharma Inc

What is Valuation History?
Compare IMMX to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about IMMX?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Immix Biopharma Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Immix Biopharma Inc

Current Assets 16.8m
Cash & Short-Term Investments 15.9m
Other Current Assets 858.1k
Non-Current Assets 3.1m
PP&E 3.1m
Other Non-Current Assets 20.4k
Efficiency

Free Cash Flow Analysis
Immix Biopharma Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Immix Biopharma Inc

Revenue
0 USD
Operating Expenses
-21.8m USD
Operating Income
-21.8m USD
Other Expenses
870.6k USD
Net Income
-20.9m USD
Fundamental Scores

IMMX Profitability Score
Profitability Due Diligence

Immix Biopharma Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Exceptional ROIC
ROE is Increasing
Low 3Y Average Gross Margin
50/100
Profitability
Score

Immix Biopharma Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

IMMX Solvency Score
Solvency Due Diligence

Immix Biopharma Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
51/100
Solvency
Score

Immix Biopharma Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IMMX Price Targets Summary
Immix Biopharma Inc

Wall Street analysts forecast IMMX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMMX is 7.14 USD with a low forecast of 7.07 USD and a high forecast of 7.35 USD.

Lowest
Price Target
7.07 USD
211% Upside
Average
Price Target
7.14 USD
215% Upside
Highest
Price Target
7.35 USD
224% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Immix Biopharma Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for IMMX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

IMMX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one IMMX stock?

The intrinsic value of one IMMX stock under the Base Case scenario is 3.08 USD.

Is IMMX stock undervalued or overvalued?

Compared to the current market price of 2.27 USD, Immix Biopharma Inc is Undervalued by 26%.

Back to Top